StockWatch
·

Inventurus Knowledge Solutions Ltd

BSE: 544309

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
476.73
+15.1%+48.2%
Expenditure
270.35
+25.3%+50.4%
Net Profit
162.55
-3.8%+44.0%
OPM %
46.17%
-5.08pp-0.70pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00133.48266.97400.45533.93Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Solid YoY Growth, But the Market Didn't Buy the Story

TruBridge integration · AI strategy · margin expansion

Result verdictFollow-upQ1 FY2716 Aug 20266 minTechnology / IT

Solid Q1 with 20.7% YoY growth, but QoQ momentum fades amid integration execution risk

TruBridge integration · AI/SLM strategy · margin expansion

TranscriptDeep diveQ1 FY2716 Aug 20266 minTechnology / IT

IKS Health Q1 FY27: consolidated PAT +28% YoY to ₹193.7 Cr, margins expand

healthcare tech services · revenue cycle management · margin expansion

ResultsQ1 FY2705 Aug 20263 minTechnology / IT
Latest
Board Meeting5 Aug, 10:20 pm

IKS Health Q1 FY27: consolidated PAT +28% YoY to ₹193.7 Cr, margins expand

Inventurus Knowledge Solutions (IKS Health) reported consolidated revenue of ₹893.6 Cr for Q1 FY27, up 20.75% YoY (740.1 Cr) and 4.19% QoQ (857.7 Cr), with consolidated PAT of ₹193.7 Cr, up 27.84% YoY (151.5 Cr) but down 5.94% QoQ (206.0 Cr). Basic EPS rose to ₹11.56 from ₹9.07 a year ago. Consolidated NPM expanded to 21.55% from 20.39% YoY, and OPM to 33.01% from 32.12% YoY — both compressed sequentially from 23.88%/35.01% in Q4 FY26, so the YoY story is growth-with-margin-expansion while the QoQ read is a seasonal-style cooling rather than a red flag. Standalone (India-entity) PAT of ₹162.5 Cr grew a much sharper 44.0% YoY on revenue up 48.8% YoY (₹475.3 Cr) — standalone growth materially outpaced consolidated growth, reflecting that the larger, slower-growing US step-down subsidiary base (Aquity, IKS Inc.) dilutes the group number; readers comparing the two should not read the standalone print as the headline. On drivers: finance cost fell to ₹10.1 Cr from ₹18.1 Cr YoY (-44%), aiding PBT even before TruBridge's deal-financing layers on next quarter, consistent with management's stated deleveraging intent. Employee benefit expense rose to ₹455.0 Cr from ₹396.0 Cr YoY (455.0 Cr vs 418.4 Cr QoQ) and other expenses to ₹143.8 Cr from ₹106.4 Cr YoY, the main drags on the OPM print. The effective tax rate was 22.79% (tax ₹57.2 Cr / PBT ₹250.9 Cr), essentially in line with management's prior-concall guidance of ~22% for the FY27 core business — guidance met. Management gave no formal quarterly revenue/PAT guidance this print, only the FY30 'True North' target to triple EBITDA to ~₹3,000 Cr, contingent on TruBridge integration. Against the Street: Univest/Uniresearch's pre-result trailing-growth preview had pegged Q1 FY27 revenue at ₹820-943 Cr and PAT at ₹186-237 Cr; the actual ₹893.6 Cr revenue and ₹193.7 Cr PAT both landed inside that range, revenue toward the upper-middle and PAT toward the lower end — an inline print rather than a beat. Analyst target-price clustering of ₹1,880-1,900 versus a pre-result price near ₹1,848.9 (per the same preview) implied only modest upside, with the Street debate centred on TruBridge integration risk (net debt ~$2,500 Cr, ~15-16x EBITDA pre-synergy) against the deal's asset quality (~$347M revenue, ~20% EBITDA conversion). This quarter's corporate actions largely support that integration narrative: the $557M TruBridge acquisition closed July 9, 2026 (a non-adjusting subsequent event, though a pre-existing software-license sale to TruBridge was recognized as revenue this quarter), ARAI Solutions was consolidated from May 14, 2026 for ₹11 Cr cash, and IKS Inc. raised its stake in IKS WWMG MSO LLC to 51.88% on the last day of the quarter (no P&L impact yet, still equity-accounted). The Board separately approved the retirement of Non-Executive Chairman Berjis Desai post-AGM and designated Clarence Carleton King II as his successor, unrelated to the financial print. Q2 FY27 becomes the first quarter to consolidate TruBridge's revenue and cost base — a step-change in scale and leverage — so integration execution, not the still-strong organic India growth, will be the swing factor for margin trajectory and any FY27-28 guidance refinement.

5 Aug 2026, 10:20 pm

Corporate Events

Board MeetingIKS
2026
21Sep

Board Meeting

The 20th Annual General Meeting ('AGM') of the Company will …

BSE Filing
Board MeetingIKS
2026
5Aug

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing
Board MeetingIKS
2026
29Jun

Board Meeting

The Board of Directors approved additional investment by Inv…

BSE Filing
Board MeetingIKS
2026
20Feb

Board Meeting

Consideration and approval of grant of employee stock option…

BSE Filing